Economic Notes: opportunity cost.
作者信息
Palmer S, Raftery J
机构信息
Centre for Health Economics, University of York, York YO1 5DD.
出版信息
BMJ. 1999 Jun 5;318(7197):1551-2. doi: 10.1136/bmj.318.7197.1551.
Abstract
摘要
相似文献
1
Economic Notes: opportunity cost.经济笔记：机会成本。
BMJ. 1999 Jun 5;318(7197):1551-2. doi: 10.1136/bmj.318.7197.1551.
2
When Opportunity Knocks, What Does It Say?当机遇来敲门时，它会说什么？
Value Health. 2019 Aug;22(8):851-853. doi: 10.1016/j.jval.2019.05.008. Epub 2019 Jul 27.
3
Prognosis without treatment as a modifier in health economic assessments.作为健康经济评估中一项修正因素的未经治疗的预后情况。
BMJ. 2005 Jun 11;330(7504):1382-4. doi: 10.1136/bmj.330.7504.1382.
4
Theory and methods of economic evaluation of health care.医疗保健经济评估的理论与方法。
Dev Health Econ Public Policy. 1996;4:1-245.
5
Economics, QALYs and medical ethics: a practical agenda?经济学、质量调整生命年与医学伦理学：一项切实可行的议程？
Health Care Anal. 1995 Aug;3(3):229-32. doi: 10.1007/BF02197673.
6
The DH register of cost-effectiveness studies: content and quality.卫生保健成本效益研究数据库：内容与质量
Health Trends. 1995;27(2):50-6.
7
Economics, QALYs and medical ethics--a health economist's perspective.经济学、质量调整生命年与医学伦理学——一位卫生经济学家的视角
Health Care Anal. 1995 Aug;3(3):221-6. doi: 10.1007/BF02197671.
8
Review of NICE's recommendations, 1999-2005.英国国家卫生与临床优化研究所（NICE）1999 - 2005年建议回顾。
BMJ. 2006 May 27;332(7552):1266-8. doi: 10.1136/bmj.332.7552.1266.
9
Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.拒绝并不容易——英国国家卫生与临床优化研究所的艰难处境。
N Engl J Med. 2008 Nov 6;359(19):1977-81. doi: 10.1056/NEJMp0806862.
10
How much are Americans willing to pay for a quality-adjusted life year?美国人愿意为一个质量调整生命年支付多少钱？
Med Care. 2008 Apr;46(4):343-5. doi: 10.1097/MLR.0b013e31816a7144.
引用本文的文献
1
Exploratory analysis of the economically justifiable price of reslizumab for asthma severe in Colombia.哥伦比亚重度哮喘患者使用瑞利珠单抗的经济合理价格探索性分析。
BMC Public Health. 2025 Jun 6;25(1):2116. doi: 10.1186/s12889-025-23205-1.
2
Quantifying societal burden of radiation-induced small bowel toxicity in patients with rectal cancer.量化直肠癌患者放射性小肠毒性的社会负担。
Front Oncol. 2024 Jul 8;14:1340081. doi: 10.3389/fonc.2024.1340081. eCollection 2024.
3
Twentieth-Century Change in the Educational Costs of Adolescent Childbearing.20世纪青少年生育的教育成本变化。
AJS. 2024 May;129(6):1763-1791. doi: 10.1086/729819.
4
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.解决经济评价中患者异质性问题的进展：方法文献综述。
Pharmacoeconomics. 2024 Jul;42(7):737-749. doi: 10.1007/s40273-024-01377-9. Epub 2024 Apr 27.
5
Reporting time toxicity in prospective cancer clinical trials: A scoping review.前瞻性癌症临床试验中的报告时间毒性：范围综述。
Support Care Cancer. 2024 Apr 8;32(5):275. doi: 10.1007/s00520-024-08487-2.
6
The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations.人工智能在医疗领域的应用不足：机会成本、成功案例、风险与建议。
Health Technol (Berl). 2024;14(1):1-14. doi: 10.1007/s12553-023-00806-7. Epub 2023 Dec 12.
7
Global HIV Incidence Analysis and Implications for Affordability Using Long-Acting Cabotegravir Versus Continuous and Event-Driven Oral Preexposure Prophylaxis.全球 HIV 发病率分析及使用长效卡替拉韦与连续和事件驱动的口服暴露前预防的可负担性影响。
Clin Infect Dis. 2024 Feb 17;78(2):386-394. doi: 10.1093/cid/ciad537.
8
Screening for primary prevention of fragility fractures: How much time does it take?筛查脆性骨折的一级预防：需要多长时间？
Can Fam Physician. 2023 Aug;69(8):537-541. doi: 10.46747/cfp.6908537.
9
Offering No-Cost Cosmetic Revisions: The Experience of an Academic Cosmetic Surgery Program.提供免费的美容修复：一个学术性美容外科项目的经验
Aesthet Surg J Open Forum. 2023 Mar 29;5:ojad033. doi: 10.1093/asjof/ojad033. eCollection 2023.
10
No such thing as a free lunch: The direct marginal costs of breastfeeding.天下没有免费的午餐：母乳喂养的直接边际成本。
J Perinatol. 2023 May;43(5):678-682. doi: 10.1038/s41372-023-01646-z. Epub 2023 Mar 22.
本文引用的文献
1
A practical guide for calculating indirect costs of disease.疾病间接成本计算实用指南。
Pharmacoeconomics. 1996 Nov;10(5):460-6. doi: 10.2165/00019053-199610050-00003.
2
Perspectives in economic evaluation.经济评估的视角
BMJ. 1998 May 16;316(7143):1529-30. doi: 10.1136/bmj.316.7143.1529.
3
Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.经济评估中的间接成本：未支付投入的机会成本。
Health Econ. 1996 Jan-Feb;5(1):13-23. doi: 10.1002/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J.
4
Marginal costs and benefits.边际成本与收益。
BMJ. 1996 Jan 6;312(7022):35-6. doi: 10.1136/bmj.312.7022.35.
5
Costs and cost-minimisation analysis.成本与成本最小化分析。
BMJ. 1993 Sep 18;307(6906):726-8. doi: 10.1136/bmj.307.6906.726.
6
Opportunity costs in modern medicine.
Health Aff (Millwood). 1992 Summer;11(2):162-9. doi: 10.1377/hlthaff.11.2.162.
Zotero 插件